Telesis Bio Inc.
13F holders, Q1 2024 (March 31)21holders
1famous investor
$0.44avg. 13F price*
At the end of Q1 2024, 21 institutions reported holding Telesis Bio Inc. in their 13F filings. The largest holders were Northpond Ventures, LLC ($4.3M), Vanguard Group Inc. ($184K) and Millennium Management ($102K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Telesis Bio Inc.
- CUSIP
- 192003101
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $9K |
| Exits | 6 | $177K |
Ownership 21 holders
| Northpond Ventures, LLC | 4.22% | No change | 9,844,130 | $4.3M |
| Vanguard Group Inc. | 0.00% | No change | 418,293 | $184K |
| Millennium Management | 0.00% | Reduce -21.9% | 232,395 | $102K |
| Geode Capital Management, LLC | 0.00% | No change | 83,561 | $37K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 67,000 | $29K |
| Vontobel Holding Ltd. | 0.00% | No change | 50,000 | $22K |
| UBS Group AG | 0.00% | Add +14544.9% | 42,763 | $19K |
| BlackRock Inc. | 0.00% | Reduce -4.0% | 24,830 | $11K |
| State Street Corp. | 0.00% | No change | 21,800 | $10K |
| DF Dent & Co. Inc. | 0.00% | New | 20,000 | $9K |
| Northern Trust Corp. | 0.00% | No change | 15,937 | $7K |
| Bank of America Corp. | 0.00% | Reduce -0.1% | 6,000 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +13400.0% | 3,105 | $1K |
| Dynamic Wealth Strategies, LLC | 0.00% | No change | 2,470 | $1K |
| JPMorgan Chase & Co. | 0.00% | Add +4.5% | 533 | $234 |
| Qube Research & Technologies Ltd | 0.00% | Add +10000.0% | 404 | $178 |
| Osaic Holdings, Inc. | 0.00% | No change | 225 | $99 |
| Wells Fargo & Company | 0.00% | Add +1.4% | 70 | $31 |
| Citigroup Inc. | 0.00% | No change | 6 | $3 |
| Royal Bank of Canada | 0.00% | Reduce -49.2% | 127 | $0 |
| Simplex Trading, LLC | 0.00% | Reduce -97.5% | 100 | $0 |
"% of holder's portfolio" is TELESIS BIO INC's weight in each manager's 13F, not the share of Telesis Bio Inc. the manager owns.